Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 678 | 0 | 0 | 0 | 0 |
| Gross Profit | 678 | N/A | N/A | N/A | N/A |
| Operating Expenses | 27,755 | 30,173 | 32,468 | 32,620 | 31,406 |
| Operating Income | -27,077 | -30,173 | -32,468 | -32,620 | -31,406 |
| Other Income | 55 | 31 | 28 | 44 | 105 |
| Pre-tax Income | -27,022 | -30,142 | -32,440 | -32,576 | -31,301 |
| Income Tax | N/A | -1,000 | N/A | N/A | N/A |
| Net Income Continuous | -27,022 | -29,142 | -32,440 | -32,576 | -31,301 |
| Net Income | $-27,022 | $-29,142 | $-32,440 | $-32,576 | $-31,301 |
| EPS Basic Total Ops | -0.43 | -0.46 | -0.52 | -0.61 | -0.56 |
| EPS Basic Continuous Ops | -0.43 | -0.46 | -0.52 | -0.61 | -0.56 |
| EPS Diluted Total Ops | -0.43 | -0.46 | -0.52 | -0.61 | -0.56 |
| EPS Diluted Continuous Ops | -0.43 | -0.46 | -0.52 | -0.61 | -0.56 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.46 | N/A | N/A | N/A |
| EBITDA(a) | $-26,908 | $-29,940 | $-32,220 | $-32,449 | $-31,341 |